Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.32157 | 91 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.23733 | 90 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.0946 | 89 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.07604 | 88 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.0544 | 89 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.38413 | 92 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.10948 | 91 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.20781 | 90 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.21542 | 90 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.3851 | 91 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.38911 | 91 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.33118 | 90 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.1771 | 90 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.21641 | 90 |